SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001493152-22-028922
Filing Date
2022-10-19
Accepted
2022-10-19 17:28:37
Documents
5

Document Format Files

Seq Description Document Type Size
1 formdefa14a.htm DEFA14A 27227
2 formdefa14a_001.jpg GRAPHIC 278690
3 formdefa14a_002.jpg GRAPHIC 161032
4 formdefa14a_003.jpg GRAPHIC 256668
5 formdefa14a_004.jpg GRAPHIC 166854
  Complete submission text file 0001493152-22-028922.txt   1217133
Mailing Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477
Business Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477 203-434-3290
Greenwich LifeSciences, Inc. (Filer) CIK: 0001799788 (see all company filings)

IRS No.: 205473709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39555 | Film No.: 221319308
SIC: 2834 Pharmaceutical Preparations